Compare VREX & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VREX | EMBC |
|---|---|---|
| Founded | 2016 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 580.6M | 602.3M |
| IPO Year | 2016 | 2021 |
| Metric | VREX | EMBC |
|---|---|---|
| Price | $11.51 | $9.10 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | $16.67 | ★ $18.50 |
| AVG Volume (30 Days) | 349.0K | ★ 918.3K |
| Earning Date | 05-12-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 6.36% |
| EPS Growth | N/A | ★ 20.90 |
| EPS | 0.05 | ★ 0.74 |
| Revenue | ★ $811,000,000.00 | N/A |
| Revenue This Year | $5.35 | $1.17 |
| Revenue Next Year | $3.88 | N/A |
| P/E Ratio | $251.80 | ★ $12.79 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.76 | $9.20 |
| 52 Week High | $14.57 | $15.55 |
| Indicator | VREX | EMBC |
|---|---|---|
| Relative Strength Index (RSI) | 25.83 | 28.44 |
| Support Level | $11.43 | N/A |
| Resistance Level | $11.94 | $10.88 |
| Average True Range (ATR) | 0.41 | 0.33 |
| MACD | -0.19 | -0.07 |
| Stochastic Oscillator | 0.68 | 3.26 |
Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.